johnsmithnevadaus created a new article
2 yrs

Is Paxalisib Better Than Temozolomide In The First-Line Setting? | #newly Diagnosed Glioblastoma # asco 2022 conference # asco conference 2022 # asco abstract 2022

Is Paxalisib Better Than Temozolomide In The First-Line Setting?

Is Paxalisib Better Than Temozolomide In The First-Line Setting?

Paxalisib's mechanism of action involves directly suppressing PI3K in the PI3K/AKT kinase (also known as protein kinase B) signalling pathway, which prevents the PI3K signalling pathway from being activated. In sensitive tumour cell populations, this may prevent both cell growth and